Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract Background: Parkinson’s disease (PD) is increasingly recognized as a multisystem neurode-generative disorder in which gastrointestinal dysfunction, microbial ecology, immune signaling, and nigrostriatal vulnerability intersect. Microbiome studies have identified PD-associated gut microbial alterations, but translating these observations into host-relevant biological axes requires integration across microbial functions, metabolites, host genes, and brain-region transcriptomic context. Methods: MiNi-PD was developed as a lightweight, fully in silico, table-level priori-tization workflow integrating processed PD microbiome features, curated microbe–metabolite– host-gene associations from gutMGene v2.0, and processed substantia nigra and putamen transcriptomic support from GSE136666. The framework ranks microbe–metabolite–host-gene axes using exact-curated metabolite-mediated evidence, brain-region support, and a normalized Nigrostriatal Gut-Brain Convergence Score (NGBCS). Results: Strict evidence filtering retained 639 primary exact-curated metabolite-mediated axes. Of these, 12 had FDR-level brain transcrip-tomic support and 65 had nominal-or-stronger support. IL1B emerged as the principal FDR-level host-gene convergence point. SCFA-linked metabolites dominated the primary exact-curated set, including 387 butyrate axes and 5 3-indolepropionic-acid axes. The FDR-supported axes reached the maximum NGBCS value of 5.0, while the top nominally supported axes reached the high-priority NGBCS value of 4.5. Conclusion: MiNi-PD identifies a focused SCFA-linked gut-brain signature in PD, highlighting butyrate-and 3-indolepropionic-acid-associated links to IL1B as a biologically meaningful substantia nigra-supported inflammatory axis. The NGBCS framework provides an accessible and interpretable route for prioritizing metabolite-mediated gut-brain mechanisms for downstream validation.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.